ID   FMS
AC   CVCL_9V01
SY   FMSmel; FMS mel
DR   Wikidata; Q54835090
RX   PubMed=9331097;
RX   PubMed=10395702;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
RX   PubMed=10395702; DOI=10.4049/jimmunol.163.2.1037;
RA   Yang, Rong-Cun
RA   Salazar-Onfray, Flavio
RA   Charo, Jehad
RA   Malmberg, Karl-Johan
RA   Evrin, Kristina
RA   Maes, Hubert
RA   Kono, Koji
RA   Hising, Christina
RA   Petersson, Max
RA   Larsson, Olle
RA   Lan, Li
RA   Appella, Ettore
RA   Sette, Alessandro
RA   Celis, Esteban
RA   Kiessling, Rolf
RT   "Identification of new HER2/neu-derived peptide epitopes that can
RT   elicit specific CTL against autologous and allogeneic carcinomas and
RT   melanomas.";
RL   J. Immunol. 163:1037-1044(1999).
//
RX   PubMed=9331097;
RA   Salazar-Onfray, Flavio
RA   Nakazawa, Tsutomu
RA   Chhajlani, Vijay
RA   Petersson, Max
RA   Karre, Klas
RA   Masucci, Giuseppe
RA   Celis, Esteban
RA   Sette, Alessandro
RA   Southwood, Scott
RA   Appella, Ettore
RA   Kiessling, Rolf
RT   "Synthetic peptides derived from the melanocyte-stimulating hormone
RT   receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes
RT   that recognize naturally processed peptides on human melanoma
RT   cells.";
RL   Cancer Res. 57:4348-4355(1997).
//